Paper32085552
Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma.
Kamimura K and 12 others. Cancers (Basel), 2020. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma. Papers, record 32085552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32085552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 22890064, 23790595, 26860354, and 17K09408 | Japan Society for the Promotion of Science | PubMed | ||
| 2013 | Takara Bio Award from JSGT | PubMed | ||
| JP19fk0210042 | Japan agency for Medical Research and Development | PubMed |
Source PubMed
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27064257 | Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. | Nat Genet | 2016 | https://conductscience.org/library/papers/27064257 | PubMed |
| 2 | 31195063 | Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis. | J Hepatol | 2019 | https://conductscience.org/library/papers/31195063 | PubMed |
| 3 | 25537775 | Current status of gene therapy for hepatocellular carcinoma, with a focus on gene delivery approaches. | Curr Gene Ther | 2015 | https://conductscience.org/library/papers/25537775 | PubMed |
| 4 | 23187456 | Exploiting the Intron-splicing Mechanism of Insect Cells to Produce Viral Vectors Harboring Toxic Genes for Suicide Gene Therapy. | Mol Ther Nucleic Acids | 2012 | https://conductscience.org/library/papers/23187456 | PubMed |
| 5 | 26730813 | Effective Prevention of Liver Fibrosis by Liver-targeted Hydrodynamic Gene Delivery of Matrix Metalloproteinase-13 in a Rat Liver Fibrosis Model. | Mol Ther Nucleic Acids | 2016 | https://conductscience.org/library/papers/26730813 | PubMed |
| 6 | 22200988 | Advances in Gene Delivery Systems. | Pharmaceut Med | 2011 | https://conductscience.org/library/papers/22200988 | PubMed |
| 7 | 19083101 | Physical approaches for nucleic acid delivery to liver. | AAPS J | 2008 | https://conductscience.org/library/papers/19083101 | PubMed |
| 8 | 23359128 | Diphtheria Toxin/Human B-Cell Activating Factor Fusion Protein Kills Human Acute Lymphoblastic Leukemia BALL-1 Cells: An Experimental Study. | Chin J Cancer Res | 2012 | https://conductscience.org/library/papers/23359128 | PubMed |
| 9 | 11124054 | Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells. | Mol Ther | 2000 | https://conductscience.org/library/papers/11124054 | PubMed |
| 10 | 31500650 | From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31500650 | PubMed |
| 11 | 8271974 | Suppressive effect of liposomes containing DNA coding for diphtheria toxin A-chain on cells transformed with bovine leukemia virus. | Microbiol Immunol | 1993 | https://conductscience.org/library/papers/8271974 | PubMed |
| 12 | 27838634 | Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer. | Carcinogenesis | 2017 | https://conductscience.org/library/papers/27838634 | PubMed |
| 13 | 23945077 | Receptor-directed chimeric toxins created by sortase-mediated protein fusion. | Mol Cancer Ther | 2013 | https://conductscience.org/library/papers/23945077 | PubMed |
| 14 | 31290997 | Immune checkpoint inhibitors for hepatocellular carcinoma. | Cancer | 2019 | https://conductscience.org/library/papers/31290997 | PubMed |
| 15 | 7833808 | Refined structure of monomeric diphtheria toxin at 2.3 A resolution. | Protein Sci | 1994 | https://conductscience.org/library/papers/7833808 | PubMed |
| 16 | 15233950 | Optimization of a synthetic beta-catenin-dependent promoter for tumor-specific cancer gene therapy. | Mol Ther | 2004 | https://conductscience.org/library/papers/15233950 | PubMed |
| 17 | 18950807 | Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. | J Urol | 2008 | https://conductscience.org/library/papers/18950807 | PubMed |
| 18 | 26795574 | Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. | Gastroenterology | 2016 | https://conductscience.org/library/papers/26795574 | PubMed |
| 19 | 31963820 | Mechanical Forces as Determinants of Disseminated Metastatic Cell Fate. | Cells | 2020 | https://conductscience.org/library/papers/31963820 | PubMed |
| 20 | 29378174 | Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans. | Am J Pathol | 2018 | https://conductscience.org/library/papers/29378174 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38966543 | Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38966543 | PubMed |
| 38361756 | A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma. | Oncol Res | 2024 | https://conductscience.org/library/papers/38361756 | PubMed |
| 37663132 | Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives. | Mol Ther Oncolytics | 2023 | https://conductscience.org/library/papers/37663132 | PubMed |
| 37111597 | Hydrodynamic Delivery: Characteristics, Applications, and Technological Advances. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37111597 | PubMed |
| 36160029 | HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma. | Biochem Biophys Rep | 2022 | https://conductscience.org/library/papers/36160029 | PubMed |
| 36136517 | From Immunotoxins to Suicide Toxin Delivery Approaches: Is There a Clinical Opportunity? | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36136517 | PubMed |
| 35474735 | Establishment of a pancreatic cancer animal model using the pancreas-targeted hydrodynamic gene delivery method. | Mol Ther Nucleic Acids | 2022 | https://conductscience.org/library/papers/35474735 | PubMed |
| 35453686 | Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma. | Biology (Basel) | 2022 | https://conductscience.org/library/papers/35453686 | PubMed |
| 32634464 | In vivo gene delivery mediated by non-viral vectors for cancer therapy. | J Control Release | 2020 | https://conductscience.org/library/papers/32634464 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32085552
GET https://conductscience.org/api/papers/v1/32085552/references?page=2